Andrei Ivancuta

Cluj-napoca, CJ 400349, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

The crosstalk between epigenetics and metabolism in the malignant cell.

The crosstalk between epigenetics and metabolism in the malignant cell.

Journal: Discover oncology

Published: December 10, 2025

Patient-centered and coordinated therapy with RNA interference-based givosiran for acute hepatic porphyria: real-life experience for an ultra-rare disease from Romania.

Patient-centered and coordinated therapy with RNA interference-based givosiran for acute hepatic porphyria: real-life experience for an ultra-rare disease from Romania.

Journal: Blood science (Baltimore, Md.)

Published: September 23, 2025

Proteolysis targeting chimeric-based technology in myeloma and lymphoma.

Proteolysis targeting chimeric-based technology in myeloma and lymphoma.

Journal: Molecular cancer therapeutics

Published: September 22, 2025

Proteolysis Targeting Chimeric-Based Technology in Myeloma and Lymphoma.

Proteolysis Targeting Chimeric-Based Technology in Myeloma and Lymphoma.

Journal: Molecular cancer therapeutics

Published: September 22, 2025

Snapshot Look at Castleman Disease.

Snapshot Look at Castleman Disease.

Journal: Journal of cellular and molecular medicine

Published: August 11, 2025

In-depth analysis for TKI-driven real-world management of 201 CML patients using TFR.

In-depth analysis for TKI-driven real-world management of 201 CML patients using TFR.

Journal: Frontiers in pharmacology

Published: July 25, 2025

CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases.

CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases.

Journal: Blood reviews

Published: July 23, 2025

Advances in measurable residual disease assessment for acute myeloid leukemia: from cytogenetics and molecular biology to assessment of the methylation pattern and surface-enhanced Raman scattering as emerging technologies.

Advances in measurable residual disease assessment for acute myeloid leukemia: from cytogenetics and molecular biology to assessment of the methylation pattern and surface-enhanced Raman scattering as emerging technologies.

Journal: Biomarker research

Published: July 16, 2025

Epigenetic Therapies in Melanoma-Targeting DNA Methylation and Histone Modification.

Epigenetic Therapies in Melanoma-Targeting DNA Methylation and Histone Modification.

Journal: Biomedicines

Published: April 01, 2025

Showing 1-9 of 9

Last Updated: 09/26/2026